Global Metastatic Breast Cancer Pipeline Report 2016 - Pipeline Review of 128 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Metastatic Breast Cancer - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Metastatic Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Breast Cancer) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Metastatic Breast Cancer Overview
  3. Therapeutics Development
  4. Pipeline Products for Metastatic Breast Cancer - Overview
  5. Pipeline Products for Metastatic Breast Cancer - Comparative Analysis
  6. Metastatic Breast Cancer - Therapeutics under Development by Companies
  7. Metastatic Breast Cancer - Therapeutics under Investigation by Universities/Institutes
  8. Metastatic Breast Cancer Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Metastatic Breast Cancer - Products under Development by Companies
  13. Metastatic Breast Cancer - Products under Investigation by Universities/Institutes
  14. Metastatic Breast Cancer - Companies Involved in Therapeutics Development
  • AB Science SA
  • AbbVie Inc.
  • Acceleron Pharma, Inc.
  • Acetylon Pharmaceuticals, Inc.
  • Adgero Biopharmaceuticals, Inc.
  • Advaxis, Inc.
  • Advenchen Laboratories, LLC
  • Alteogen Inc.
  • Amarna Therapeutics B.V.
  • Ambrx, Inc.
  • Amgen Inc.
  • Aphios Corporation
  • arGEN-X BV
  • Aslan Pharmaceuticals Pte. Ltd.
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Beta Pharma, Inc.
  • Biocon Limited
  • Bionovis SA
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Campus Technologies Freiburg GmbH
  • CASI Pharmaceuticals Inc.
  • Celgene Corporation
  • Celldex Therapeutics, Inc.
  • Cellectar Biosciences, Inc.
  • Celltrion, Inc.
  • Clovis Oncology, Inc.
  • Corcept Therapeutics Incorporated
  • Curadis GmbH
  • Curaxys, S.L.
  • Daiichi Sankyo Company, Limited
  • Deciphera Pharmaceuticals, LLC
  • DexTech Medical AB

For more information visit http://www.researchandmarkets.com/research/8flk3x/metastatic_breast

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women's Health, Breast Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women's Health, Breast Cancer Drugs